|
BIND Therapeutics Announces Proposed Public Offering of Common Stock and …
MarketWatch … developing targeted and programmable therapeutics called Accurins™, today announced that it is commencing an underwritten public offering of units consisting of shares of BIND’s common stock and warrants to purchase shares of BIND’s common stock. |
